Therapeutics: Receptor-interacting serine threonine kinase 1 (RIPK1; RIP1); RIPK3 (RIP3)

Human sample and mouse studies suggest inhibiting RIPK1 and RIPK3 could help treat MS. Levels of RIPK1 and RIPK3 were higher in cortical samples from MS patients than in samples from healthy controls....